Remesh Arun Thachappully, Alagarasu Kalichamy, Jadhav Santoshkumar, Prabhakar Meera, Viswanathan Rajlakshmi
Bacteriology Group, ICMR-National Institute of Virology, Pune 411021, India.
Dengue-Chikungunya Group, ICMR-National Institute of Virology, Pune 411001, India.
Vaccines (Basel). 2024 Feb 28;12(3):253. doi: 10.3390/vaccines12030253.
Pertussis, or whooping cough, is a global public health concern. Pertussis vaccines have demonstrated good protection against infections, but their effectiveness against remains debated due to conflicting study outcomes.
A systematic review and meta-analysis were conducted to assess the effectiveness of pertussis vaccines in protecting children against infection. A comprehensive search of PubMed, Web of Science, and Scopus databases was conducted, and randomized controlled trials (RCTs) and observational studies that met inclusion criteria were included in the analysis.
The meta-analysis, involving 46,533 participants, revealed no significant protective effect of pertussis vaccination against infection (risk ratio: 1.10, 95% confidence interval: 0.83 to 1.44). Subgroup analyses by vaccine type and study design revealed no significant protection. The dearth of recent data and a limited pool of eligible studies, particularly RCTs, underscore a critical gap that warrants future research in the domain.
These findings offer crucial insights into the lack of effectiveness of pertussis vaccines against . Given the rising incidence of cases and outbreaks, coupled with the lack of cross-protection by the existing vaccines, there is an urgent need to develop vaccines that include specific antigens to protect against .
百日咳,即小儿咳嗽,是一个全球公共卫生问题。百日咳疫苗已证明对感染有良好的保护作用,但由于研究结果相互矛盾,其对[此处原文缺失相关内容]的有效性仍存在争议。
进行了一项系统综述和荟萃分析,以评估百日咳疫苗在保护儿童免受[此处原文缺失相关内容]感染方面的有效性。对PubMed、科学网和Scopus数据库进行了全面检索,并将符合纳入标准的随机对照试验(RCT)和观察性研究纳入分析。
这项涉及46,533名参与者的荟萃分析显示,百日咳疫苗接种对[此处原文缺失相关内容]感染没有显著的保护作用(风险比:1.10,95%置信区间:0.83至1.44)。按疫苗类型和研究设计进行的亚组分析显示没有显著的保护作用。近期数据的匮乏以及合格研究(特别是RCT)的有限数量凸显了一个关键差距,这需要该领域未来进行研究。
这些发现为百日咳疫苗对[此处原文缺失相关内容]缺乏有效性提供了重要见解。鉴于病例和疫情的发病率不断上升,再加上现有疫苗缺乏交叉保护作用,迫切需要开发包含特定抗原以预防[此处原文缺失相关内容]的疫苗。